| 1 |
Kubicek, M., Pacher, M., Abraham, D., Podar, K., Eulitz, M. and Baccarini, M. (2002): Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J. Biol. Chem., 277, 7913-7919
DOI
ScienceOn
|
| 2 |
Romanelli, A, Martin, K.A., Toker, A. and Blenis, J. (1999): p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell Biol., 19, 2921-2928
DOI
|
| 3 |
Shields, J.M., Pruitt, K, McFall, A., Shaub, .A and Der, C.J. (2000): Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol., 10, 147-154
DOI
ScienceOn
|
| 4 |
Toledo, L.M., Lydon, N.B. and Elbaum, D. (1999): The structure-based design of ATP-site directed protein kinase inhibitors. Curr. Med. Chem., 6, 775-805
|
| 5 |
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P. and Grand-Perret, T., Ajakane, M., Baudet, v., Boissin, P., Boursier, E., Loriolle, F., et al. (1991): The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266,15771-15781
|
| 6 |
Vanhaesebroeck, B. and Alessi, D.R. (2000): The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J., 346, 561-576
DOI
ScienceOn
|
| 7 |
Woodcroft, K.J., Hafner, M.S. and Novak, R.F. (2002): Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology, 35, 263-273
DOI
ScienceOn
|
| 8 |
Amarzguioui, M., Holen, T, Babaie, E. and Prydz, H. (2003): Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res., 31, 589-595
DOI
ScienceOn
|
| 9 |
Bain, J., McLauchlan, H., Elliott, M. and Cohen, P. (2003): The specificities of protein kinase inhibitors: an update. Biochem. J, 371,199-204
DOI
ScienceOn
|
| 10 |
Catling, A.D., Schaeffer, H.J., Reuter, C.W, Reddy, G.R and Weber, M.J. (1995): A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function. Mol. Cell Biol., 15, 5214-5225
DOI
|
| 11 |
Davies, S.P, Reddy, H., Caivano, M. and Cohen, P (2000): Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J, 351, 95-105
DOI
|
| 12 |
Dykxhoorn, D.M., Novina, C.D. and Sharp, P.A .(2003): Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol., 4, 457-467
DOI
ScienceOn
|
| 13 |
Fabbro, D., Parkinson, D. and MaUer, A. (2002): Protein tyrosine kinase inhibitors: new treatment modalities? Curr. Opin. Pharmacal., 2, 374-381
DOI
ScienceOn
|
| 14 |
Frantz, B., Klatt, T., Pang, M., Parsons, J., Rolando, A, Williams, H., Tocci, M.J., O'Keefe, S.J. and O'Neill, E.A (1998): The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry, 37, 13846-13853
DOI
ScienceOn
|
| 15 |
Grishok, A, Pasquinelli, A.E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D.L., Fire, A., Ruvkun, G. and Mello, C.C. (2001): Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell, 106, 23-34
DOI
ScienceOn
|
| 16 |
Kim, S.K., Woodcroft, K.J. and Novak, R.F. (2004b): Insulin and growth factor signaling in Drug Metabolism and Transport (Lash, L.H., Ed.). Humana Press, Totowa, pp. 49-83
|
| 17 |
Abdelmegeed, M.A., Carruthers, N.J., Woodcroft, K.J., Kim, SK and Novak, R.F. (2005): Acetoacetate Induces cytochrome P450 (CYP) 2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther., (in press)
DOI
PUBMED
ScienceOn
|
| 18 |
Bennett, B.L., Sasaki, D.T., Murray, B.W, O'Leary, E.C., Sakata, S.T., Xu, W, Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y, Bhagwat, S.S., Manning, A.M. and Anderson, D.W. (2001): SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA, 98, 13681-13686
DOI
ScienceOn
|
| 19 |
Kim, S.K., Woodcroft, K.J., Kim, S.G and Novak, R.F. (2003a): Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes. Drug. Metab. Dispos., 31, 1260-1268
DOI
ScienceOn
|
| 20 |
Mason, C.S., Springer, C.J., Cooper, RG, Superti-Furga, G, Marshall, C.J. and Marais, R. (1999): Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J., 18, 2137-2148
DOI
ScienceOn
|
| 21 |
Elbashir, S.M., Harborth, J., Lendeckel, W, Yalcin, A, Weber, K. and Tuschl, T. (2001a): Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498
DOI
ScienceOn
|
| 22 |
Fire, A, Xu, S., Montgomery, M.K., Kostas, SA, Driver, S.E. and Mello, C.C. (1998): Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811
DOI
ScienceOn
|
| 23 |
Blake, R.A, Broome, M.A, Liu, X., Wu, J., Gishizky, M., Sun, L. and Courtneidge, S.A (2000): SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell BioI., 20, 9018-9027
DOI
ScienceOn
|
| 24 |
Martiny-Baron, G, Kazanietz, M.G, Mischak, H., Blumberg, P.M., Kochs, G, Hug, H., Marme, D. and Schachtele, C. (1993): Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem., 268, 9194-9197
|
| 25 |
Standaert, M.L., Bandyopadhyay, G, Kanoh, Y, Sajan, M.P. and Farese, R.V .(2001): Insulin and PIP3 activate PKCzeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T 410) and autophosphorylation (T560) sites. Biochemistry, 40, 249-255
DOI
PUBMED
ScienceOn
|
| 26 |
Abdelmegeed, M.A., Kim, S.K., Woodcroft, K.J. and Novak, R.F. (2004): Acetoacetate activation of extracellular signal- regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J. Pharmacol. Exp. Ther., 310, 728-736
DOI
ScienceOn
|
| 27 |
Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001b): RNA interference is mediated by 21- and 22.-nucleotide RNAs. Genes Dev., 15, 188-200
DOI
ScienceOn
|
| 28 |
Kao, A.W., Waters, S.B., Okada, S. and Pessin, J.E. (1997): Insulin stimulates the phosphorylation of the 66- and 52kilodalton Shc isoforms by distinct pathways. Endocrinology, 138, 2474-2480
DOI
ScienceOn
|
| 29 |
Karihaloo, A., O'Rourke, D.A., Nickel, C., Spokes, K. and Cantley, L.G. (2001): Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J. Biol. Chem., 276, 9166-9173
DOI
ScienceOn
|
| 30 |
McManus, M.T., Petersen, C.P., Haines, B.B., Chen, J. and Sharp, P.A .(2002b): Gene silencing using micro-RNA designed hairpins. RNA, 8, 842-850
DOI
ScienceOn
|
| 31 |
McManus, M.T., Haines, B.B., Dillon, C.P., Whitehurst, C.E., van Parijs, L., Chen, J. and Sharp, PA (2002a): Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol., 169, 5754-5760
DOI
|
| 32 |
Williams, B.R. (1997): Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans., 25, 509-513
DOI
|
| 33 |
Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I. and Magnuson, M.A. (2000): Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Molecular. Cell, 6, 87-97
DOI
ScienceOn
|
| 34 |
Kuo, C.J., Chung, J., Fiorentino, D.F, Flanagan, W.M., Blenis, J. and Crabtree, G.R. (1992): Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature, 358,70-73
DOI
ScienceOn
|
| 35 |
Stein, R.C. (2001): Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr. Relat. Cancer., 8, 237-248
DOI
PUBMED
ScienceOn
|
| 36 |
Conus, N.M., Hemmings, BA and Pearson, RB. (1998): Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70S6k. J. Biol. Chem., 273, 4776-4782
DOI
ScienceOn
|
| 37 |
He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W and Vogelstein, B. (1998): A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, .95, 2509-2514
DOI
|
| 38 |
Paddison, P.J., Caudy, AA and Hannon G.J. (2002): Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. A cad. Sci. USA, 99, 1443-1448
DOI
ScienceOn
|
| 39 |
Alessi, D.R, Andjelkovic, M., Caudwell, B., Cron, P, Morrice, N., Cohen, P. and Hemmings, B.A (1996): Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15, 6541-6551
|
| 40 |
Cheatham, B. and Kahn, C.R (1992): Cysteine 647 in the insulin receptor is required for normal covalent interaction between alpha- and beta-subunits and signal transduction. J. Biol. Chem., 267, 7108-7115
|
| 41 |
Standaert, M.L., Bandyopadhyay, G., Perez, L., Price, D., Galloway, L., Poklepovic, A, Sajan, M.P., Cenni, V., Sirri, A, Moscat, J., Toker, A and Farese, R.V. (1999): Insulin activates protein kinases C-zeta and C-Iambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J. Biol. Chem., 274, 25308-25316
DOI
|
| 42 |
Dufner, A, Andjelkovic, M., Burgering, B.M., Hemmings, B.A and Thomas, G (1999): Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation. Mol. Cell Biol., 19, 4525-4534
DOI
|
| 43 |
Hagemann, C. and Blank, J.L. (2001): The ups and downs of MEK kinase interactions. Cell Signal., 13, 863-875
DOI
ScienceOn
|
| 44 |
Sasaoka, T. and Kobayashi, M. (2000): The functional significance of She in insulin signaling as a substrate of the insulin receptor. Endocr. J., 47, 373-381
DOI
ScienceOn
|
| 45 |
Cantley, L.C. (2002): The phosphoinositide 3-kinase pathway. Science, 296, 1655-1657
DOI
PUBMED
ScienceOn
|
| 46 |
Chong, H., Vikis, H.G and Guan, K.L. (2003): Mechanisms of regulating the Raf kinase family. Cell Signal., 15,463-469
DOI
ScienceOn
|
| 47 |
Kim, S.K., Woodcroft, K.J., Oh, S.J., Abdelmegeed, M.A. and Novak, R.F. (2005): Role of mechanical and redox stress in activation of mitogen activated protein kinases in primary cultured rat hepatocytes. Biochem. Pharmacol., (in press)
DOI
|
| 48 |
Sui, G., Soohoo, C., Affarel, B., Gay, F, Shi, Y, Forrester, W.C. and Shi, Y.A. (2002): DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, 99, 5515-5520
DOI
ScienceOn
|
| 49 |
Vlahos, C.J., Matter, W.F, Hui, K.Y and Brown, R.F. (1994): A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269, 5241-5248
|
| 50 |
Yu, J.Y., DeRuiter, S.L. and Turner DL. (2002): RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA, 99, 6047-6052
DOI
ScienceOn
|
| 51 |
Lee, N.S., Dohjima, T., Bauer, G, Li, H., Li, M.J., Ehsani, A, Salvaterra, P. and Rossi, J. (2002): Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol., 20, 500-555
DOI
ScienceOn
|
| 52 |
McManus, M.T. and Sharp, P.A .(2002): Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet., 3, 737-747
DOI
ScienceOn
|
| 53 |
Ross, A.H., Baltimore, D. and Eisen, H.N. (1981): Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten. Nature, 294, 654-656
DOI
ScienceOn
|
| 54 |
Hanke, J.H, Gardner, J.P., Dow, RL., Changelian, P.S., Brissette, W.H., Weringer, E.J., Pollok, B.A. and Connelly, P.A. (1996): Discovery of a novel, potent, and Src familyselective tyrosine kinase inhibitor. Study of Lck- and FynTdependent T cell activation. J. Biol. Chem., 271, 695-701
DOI
|
| 55 |
Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., Copeland, R.A, Magolda, R.L., Scherle, P.A. and Trzaskos, J.M. (1998): Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem., 273, 18623-18632
DOI
ScienceOn
|
| 56 |
Jefferies, H.B., Fumagalli, S., Dennis, P.B., Reinhard, C., Pearson, R.B. and Thomas, G (1997): Rapamycin sup-presses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J., 16, 3693-3704
DOI
ScienceOn
|
| 57 |
Kyriakis, J.M. and Avruch, J. (2001): Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev., 81, 807-869
DOI
|
| 58 |
Lewis, T.S., Shapiro, P.S. and Ahn, N.G (1998): Signal transduction through MAP kinase cascades. Adv. Cancer Res., 74,49-139
DOI
|
| 59 |
Davis, P.D., Hill, C.H., Keech, E., Lawton, G, Nixon, J.S., Sedgwick, A.D., Wadsworth, J., Westmacott, D. and Wilkinson, S.E. (1989): Potent selective inhibitors of protein kinase C. FEBS Lett., 259, 61-63
DOI
ScienceOn
|
| 60 |
Cherrington, A.D. (1999): Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes, 48, 1198-1214
DOI
PUBMED
ScienceOn
|
| 61 |
Kim, S.K., Woodcroft, K.J. and Novak, RF. (2003b) Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther., 305, 353-361
DOI
ScienceOn
|
| 62 |
Chan, T.O., Rittenhouse, S.E. and Tsichlis PN. (1999): AKT/ PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem., 68, 965-1014
DOI
ScienceOn
|
| 63 |
Izzard, R.A., Jackson, S.P. and Smith, G.C. (1999): Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res., 59, 2581-2586
|
| 64 |
Kohn, A.D., Takeuchi, F. and Roth, R.A. (1996): Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem., 271, 21920-21926
DOI
ScienceOn
|
| 65 |
Tzivion, G., Luo, Z. and Avruch, J. (1998): A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature, 394, 88-92
DOI
ScienceOn
|
| 66 |
House, C. and Kemp, B.E. (1987): Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science, 238, 1726-1728
DOI
PUBMED
|
| 67 |
Alessi, DR., Cuenda, A., Cohen, P., Dudley, D.T and Saltiel, A.R (1995): PO 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494
DOI
ScienceOn
|
| 68 |
Light, Y, Paterson, H. and Marais, R. (2002): 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity. Mol. Cell Biol., 22, 4984-4996
DOI
ScienceOn
|
| 69 |
Wang, L., Gout, I. and Proud, C.G (2001): Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes. J. Biol. Chem., 276, 32670-32677
DOI
ScienceOn
|
| 70 |
Brummelkamp, T.R, Bernards, R and Agami, R. (2002): A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553
DOI
PUBMED
ScienceOn
|
| 71 |
Yeh, P. and Perricaudet, M. (1997): Advances in adenoviral vectors: from genetic engineering to their biology. FASEB J., 11,615-623
DOI
|
| 72 |
Zamore, P.D., Tuschl, T., Sharp, P.A and Bartel, D.P. (2000): RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25-33
DOI
PUBMED
ScienceOn
|
| 73 |
Kim, S.K., Woodcroft, K.J., Khodadadeh, S.S. and Novak, R.F. (2004a): Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther., 311, 99-108
DOI
ScienceOn
|
| 74 |
Mendez, R, Kollmorgen, G, White, M.F. and Rhoads, R.E. (1997): Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin. Mol. Cell Biol., 17, 5184-5192
DOI
|
webmaster
